Hyperhomocysteinemia 	Hyperhomocysteinemia 	 NNP	B-NP
:  	:  	 :	O
a  	a  	 DT	O
biochemical  	biochemical  	 JJ	B-NP
link  	link  	 NN	I-NP
between  	between  	 IN	O
bone  	bone  	 NN	O
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
system  	system  	 NN	I-NP
diseases 	diseases 	 NNS	I-NP
?  	?  	 .	O
Homocysteine  	Homocysteine  	 NNP	B-NP
( 	( 	 -LRB-	O
HCY 	HCY 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
sulfur-containing  	sulfur-containing  	 JJ	O
amino  	amino  	 JJ	O
acid  	acid  	 NN	B-NP
involved  	involved  	 VBN	O
in  	in  	 IN	O
two  	two  	 CD	O
metabolic  	metabolic  	 JJ	B-NP
pathways 	pathways 	 NN	I-NP
,  	,  	 ,	O
catalized  	catalized  	 VBG	O
by  	by  	 IN	O
cystathionine-B-synthase  	cystathionine-B-synthase  	 JJ	B-NP
and  	and  	 CC	O
methionine  	methionine  	 JJ	B-NP
synthase 	synthase 	 NN	I-NP
,  	,  	 ,	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
vitamin  	vitamin  	 NNS	O
( 	( 	 -LRB-	O
vit 	vit 	 LS	B-NP
)  	)  	 -RRB-	O
B6 	B6 	 NNP	O
,  	,  	 ,	O
B12 	B12 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
folate  	folate  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
and  	and  	 CC	O
enzymatic  	enzymatic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
methylenetetrahydrofolate 	methylenetetrahydrofolate 	 NN	I-NP
.  	.  	 .	O
High  	High  	 NNP	O
HCY  	HCY  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
HHCY 	HHCY 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
cardiovascular  	cardiovascular  	 JJ	B-NP
( 	( 	 -LRB-	O
CV 	CV 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
bone  	bone  	 NN	O
diseases 	diseases 	 NNS	O
,  	,  	 ,	O
in  	in  	 IN	O
particular  	particular  	 JJ	O
osteoporosis  	osteoporosis  	 NNS	B-NP
( 	( 	 -LRB-	O
OP 	OP 	 NNP	B-NP
) 	) 	 -RRB-	O
/ 	/ 	 FW	O
hip  	hip  	 FW	B-NP
fracture 	fracture 	 FW	I-NP
.  	.  	 .	O
As  	As  	 RB	O
regards  	regards  	 VBZ	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
link  	link  	 NN	O
between  	between  	 IN	O
HHCY 	HHCY 	 NNP	B-NP
,  	,  	 ,	O
CV  	CV  	 NNP	B-NP
diseases  	diseases  	 NNS	I-NP
( 	( 	 -LRB-	O
CVD 	CVD 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
OP 	OP 	 NNP	B-NP
,  	,  	 ,	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
proposed  	proposed  	 VBN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
lysyl-oxydase  	lysyl-oxydase  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
that  	that  	 WDT	O
might  	might  	 MD	O
interfere  	interfere  	 VB	O
with  	with  	 IN	O
collagen  	collagen  	 JJ	B-NP
crosslink  	crosslink  	 JJ	I-NP
formation 	formation 	 NN	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
studies  	studies  	 NNS	O
suggested  	suggested  	 VBD	O
the  	the  	 DT	O
dysregulation  	dysregulation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
osteoprotegerin 	osteoprotegerin 	 JJ	I-NP
/ 	/ 	 CD	I-NP
receptor  	receptor  	 NN	I-NP
activator  	activator  	 NN	I-NP
of  	of  	 IN	O
nuclear  	nuclear  	 JJ	O
factor-kappaB  	factor-kappaB  	 NN	B-NP
( 	( 	 -LRB-	O
RANK 	RANK 	 NNP	B-NP
)  	)  	 -RRB-	O
ligand 	ligand 	 FW	B-NP
/ 	/ 	 FW	I-NP
RANK  	RANK  	 FW	I-NP
axis 	axis 	 FW	I-NP
,  	,  	 ,	O
others  	others  	 NNS	O
the  	the  	 DT	O
involvement  	involvement  	 NN	O
of  	of  	 IN	O
oxidative  	oxidative  	 JJ	B-NP
stress 	stress 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
mechanisms  	mechanisms  	 NNS	O
may  	may  	 MD	O
act  	act  	 VB	O
both  	both  	 DT	O
on  	on  	 IN	O
bone  	bone  	 NN	O
and  	and  	 CC	O
CV  	CV  	 NNP	O
system 	system 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
whether  	whether  	 IN	O
the  	the  	 DT	O
common  	common  	 JJ	O
denominator  	denominator  	 NN	B-NP
is  	is  	 VBZ	O
HCY  	HCY  	 NNP	B-NP
itself  	itself  	 PRP	O
or  	or  	 CC	O
HCY  	HCY  	 NNP	B-NP
is  	is  	 VBZ	O
merely  	merely  	 RB	O
a  	a  	 DT	O
marker 	marker 	 NN	O
,  	,  	 ,	O
remains  	remains  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
clearly  	clearly  	 RB	O
established 	established 	 VBN	O
.  	.  	 .	O
Folate 	Folate 	 NNP	B-NP
,  	,  	 ,	O
vit  	vit  	 CD	B-NP
B6 	B6 	 CD	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
B12  	B12  	 CD	B-NP
supplementation  	supplementation  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
HCY  	HCY  	 NNP	B-NP
reduction 	reduction 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
is  	is  	 VBZ	O
unable  	unable  	 JJ	O
to  	to  	 TO	O
certainly  	certainly  	 RB	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
OP 	OP 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
fracture  	fracture  	 NN	I-NP
and  	and  	 CC	O
CVD 	CVD 	 NNP	B-NP
,  	,  	 ,	O
probably  	probably  	 RB	O
because 	because 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
HCY  	HCY  	 NNP	B-NP
is  	is  	 VBZ	O
only  	only  	 RB	O
moderately  	moderately  	 RB	O
increased 	increased 	 VBN	O
.  	.  	 .	O
